NCT01982396View on ClinicalTrials.gov

Pharmacokinetic (PK) Study of Twice Daily vs Once Daily Lamivudine (3TC) and Abacavir (ABC) as Part of Combination Antiretroviral Therapy (ART) in HIV Infected Children

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

February 29, 2004

Study Completion Date

March 31, 2004

Conditions

HIV Infection

Interventions

DRUG

ABC Twice Daily

DRUG

ABC Once Daily

DRUG

3TC Once Daily

DRUG

3TC Twice Daily

Trial Locations (2)

Unknown

Great Ormond Street Hospital, London

St. Mary's Hospital, London

All Listed Sponsors

lead

PENTA Foundation

NETWORK

NCT01982396 - Pharmacokinetic (PK) Study of Twice Daily vs Once Daily Lamivudine (3TC) and Abacavir (ABC) as Part of Combination Antiretroviral Therapy (ART) in HIV Infected Children | Biotech Hunter | Biotech Hunter